SCLC


Ongoing protocols: click on the protocol for the inclusion and exclusion criteria (update 21/02/2019)
 

Non-metastatic stage
STIMULI (ETOP)

A Randomised Open-label Phase II Trial of Consolidation With Nivolumab and Ipilimumab in Limited-stage SCLC After Chemo-radiotherapy (Inclusion before radiotherapy).

Metastatic stage

1st line

Currently no trials

2nd line
Currently no trials

3th line
Currently no trials

New trial in start-up: currently no new trials